Patents by Inventor Yun Long

Yun Long has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10272402
    Abstract: A stirring container and a stirring apparatus are provided. The stirring container includes a barrel and a plurality of stirring paddles. The barrel is defined with an inner surface, an outer surface, and a center axis. The first opening and a second opening are located at two ends of the center axis; and the paddles are fixed on the inner surface of the barrel and extend from the first opening to the second opening and the extending directions thereof are skewed to the center axis. The stirring apparatus includes the aforesaid stirring container, a supporting structure and a rotation module. The supporting structure connects to the outer surface of the barrel to make the barrel rotatable and covers the second opening. The rotation module connects to the outer surface to rotate the stirring container. Thereby, the stirring container and the stirring apparatus can provide better stirring results.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: April 30, 2019
    Assignee: Jiyonson Co., LTD.
    Inventors: Yun-Long Tun, Shih-Ming Hsu
  • Patent number: 10265307
    Abstract: The present disclosure describes thiazole and pyridine carboxamide derivatives, their compositions and methods of use. The compounds inhibit the activity of the Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: April 23, 2019
    Assignees: Incyte Corporation, Incyte Holdings Corporation
    Inventors: Chu-Biao Xue, Hao Feng, Yun-Long Li, Ke Zhang
  • Patent number: 10270374
    Abstract: A motor driving circuit, the motor itself, and a motor driving method are disclosed. The circuit includes a controllable bidirectional alternating current (AC) switch and a processing unit, a voltage polarity of the AC power source and zero voltage crossing point of an AC power source being detected, together with a magnetic pole position of a permanent-magnet rotor, to govern the operation of the AC switch. When the controllable bidirectional AC switch is to be switched on, a trigger pulse is output after a delay time after the zero voltage crossing point, such that a phase difference between a back electromotive force and current flowing through the stator winding is decreased.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: April 23, 2019
    Assignee: JOHNSON ELECTRIC INTERNATIONAL AG
    Inventors: Chi Ping Sun, Fei Xin, Shing Hin Yeung, Xiu Wen Yang, Shu Juan Huang, Yun Long Jiang
  • Publication number: 20190115857
    Abstract: The present teaching relates to a magnetic sensor residing in a housing. The magnetic sensor includes an input port and an output port, both extending from the housing, wherein the input port is to be connected to an external alternating current (AC) power supply. The magnetic sensor also includes an electric circuit which comprises an output control circuit coupled with the output port and configured to be at least responsive to a magnetic induction signal and the external AC power supply to control the magnetic sensor to operate in a state in which a load current flows through the output port. The magnetic induction signal is indicative of at least one characteristic of an external magnetic field detected by the electrical circuit and the operating frequency of the magnetic sensor is positively proportional to the frequency of the external AC power supply.
    Type: Application
    Filed: April 10, 2018
    Publication date: April 18, 2019
    Inventors: Chi Ping SUN, Fei XIN, Ken WONG, Shing Hin YEUNG, Hui Min GUO, Shu Zuo LOU, Xiao Ming CHEN, Guang Jie CAI, Chun Fai WONG, Shu Juan HUANG, Yun Long JIANG, Yue LI, Bao Ting LIU, En Hui WANG, Xiu Wen YANG, Li Sheng LIU, Yan Yun CUI
  • Publication number: 20190084997
    Abstract: This application relates to derivatives of Formula I: and pharmaceutically acceptable salts thereof, which are inhibitors of PI3K, and compositions and methods of treatment related thereto.
    Type: Application
    Filed: August 24, 2018
    Publication date: March 21, 2019
    Inventors: Yun-Long Li, Andrew P. Combs
  • Patent number: 10220095
    Abstract: The present invention relates to pharmaceutical compositions comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent or a derivative or pharmaceutically acceptable salt thereof. The present invention also relates to methods of inhibiting cancer cell growth while reducing toxicity, comprising administering the pharmaceutical composition described herein.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: March 5, 2019
    Assignees: TAIWAN LIPOSOME COMPANY, LTD, TLC BIOPHARMACEUTICALS, INC
    Inventors: Pei Kan, Yun-Long Tseng, Han-Chun Ou, Chun-yen Lai
  • Patent number: 10205412
    Abstract: A motor driving circuit and a motor component are provided.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: February 12, 2019
    Assignee: JOHNSON ELECTRIC INTERNATIONAL AG
    Inventors: Chi Ping Sun, Shing Hin Yeung, Fei Xin, Xiu Wen Yang, Shu Juan Huang, Yun Long Jiang, Yue Li, Bao Ting Liu, En Hui Wang, Li Sheng Liu, Yan Yun Cui
  • Patent number: 10205413
    Abstract: A magnetic sensor integrated circuit, a motor assembly and an application device are provided. The integrated circuit includes a housing, a semiconductor substrate, at least one input port and an output port, and an electronic circuit arranged on the semiconductor substrate. The electronic circuit includes a rectifying circuit, a magnetic field detection circuit configured to detect an external magnetic field and output magnetic field detection information, and an output control circuit connected to the rectifying circuit, and configured to control, at least based on the magnetic field detection information, the integrated circuit to operate in at least one of a first state in which a load current flows from the output port to an outside of the integrated circuit and a second state in which a load current flows from the outside of the integrated circuit to the output port. The load current flows through the rectifying circuit.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: February 12, 2019
    Assignee: JOHNSON ELECTRIC INTERNATIONAL AG
    Inventors: Chi Ping Sun, Fei Xin, Ken Wong, Shing Hin Yeung, Shu Juan Huang, Yun Long Jiang, Yue Li, Bao Ting Liu, En Hui Wang, Xiu Wen Yang, Li Sheng Liu, Yan Yun Cui
  • Patent number: 10202398
    Abstract: Provided herein are benzimidazole derivatives, for example, of Formula (I), and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a proliferative disease.
    Type: Grant
    Filed: March 19, 2015
    Date of Patent: February 12, 2019
    Assignee: Capella Therapeutics, Inc.
    Inventor: Yun Long
  • Publication number: 20190040067
    Abstract: The present application provides methods of treating PI3K? related disorders using compounds of Formula I: or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: March 2, 2018
    Publication date: February 7, 2019
    Inventors: Yun-Long Li, Wenqing Yao, Andrew P. Combs, Eddy W. Yue, Song Mei, Wenyu Zhu, Joseph Glenn, Thomas P. Maduskuie, JR., Richard B. Sparks, Brent Douty, Chunhong He
  • Publication number: 20190031663
    Abstract: This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.
    Type: Application
    Filed: July 11, 2018
    Publication date: January 31, 2019
    Inventors: Yun-Long Li, David M. Burns, Hao Feng, Joseph Glenn, Chunhong He, Taisheng Huang, Song Mei, Jun Pan, Xiaozhao Wang, Yingda Ye
  • Publication number: 20180362546
    Abstract: The present invention provides pyrimidinones that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
    Type: Application
    Filed: April 23, 2018
    Publication date: December 20, 2018
    Inventors: Yun-Long Li, Brian W. Metcalf, Andrew P. Combs
  • Publication number: 20180343913
    Abstract: A bean roasting apparatus with a stirring barrel body, a receiving structure and an image capturing assembly is provided. The stirring barrel body has an opening. The receiving structure has a bean-through opening and an observation opening. The image capturing assembly has at least one image capturing device and a reflective surface which is disposed in the capturing scope of the at least one image capturing device and is tilted facing the at least one image capturing device and the observation opening. Therefore, the at least one image capturing device can capture an image inside the receiving structure through the reflective surface and the observation opening. Another bean roasting apparatus with an image capturing assembly is provided, wherein at least one image capturing device of the image capturing assembly can capture an image inside the receiving structure through the observation opening directly.
    Type: Application
    Filed: May 30, 2018
    Publication date: December 6, 2018
    Inventors: Yun-Long TUN, Chien-Hung CHEN, San-Chi HO
  • Publication number: 20180327412
    Abstract: This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.
    Type: Application
    Filed: May 4, 2018
    Publication date: November 15, 2018
    Inventors: Yun-Long Li, Xiaozhao Wang, Joseph Barbosa, David M. Burns, Hao Feng, Joseph Glenn, Chunhong He, Taisheng Huang, Song Mei, Jincong Zhuo
  • Patent number: 10125150
    Abstract: The present invention is related to crystalline forms of (S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one which is a PI3K inhibitor useful in the treatment of cancer and other diseases.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: November 13, 2018
    Assignee: Incyte Corporation
    Inventors: Yun-Long Li, Brian W. Metcalf, Hui-Yin Li
  • Publication number: 20180312492
    Abstract: The present invention provides compounds of Formula I: or pharmaceutically acceptable salts thereof, as well as their compositions and methods of use, that inhibit the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
    Type: Application
    Filed: February 15, 2018
    Publication date: November 1, 2018
    Inventors: Yun-Long Li, Jincong Zhuo, Ding-Quan Qian, Song Mei, Ganfeng Cao, Yongchun Pan, Qun Li, Zhongjiang Jia
  • Publication number: 20180291012
    Abstract: Provided herein are benzimidazole derivatives, for example, of Formula I, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a proliferative disease.
    Type: Application
    Filed: June 11, 2018
    Publication date: October 11, 2018
    Inventor: Yun Long
  • Patent number: 10092570
    Abstract: The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: October 9, 2018
    Assignees: Incyte Holdings Corporation, Incyte Corporation
    Inventors: Yun-Long Li, Wenqing Yao, Andrew P. Combs, Eddy W. Yue, Song Mei, Wenyu Zhu, Joseph Glenn, Thomas P. Maduskuie, Jr., Richard B. Sparks, Brent Douty, Chunhong He
  • Publication number: 20180282302
    Abstract: The present application is concerned with heterocyclic compounds that inhibit the activity of Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancers and other diseases.
    Type: Application
    Filed: January 25, 2018
    Publication date: October 4, 2018
    Inventors: Oleg Vechorkin, Yun-Long Li, Alexander Sokolsky, Anlai Wang, Wenyu Zhu, Jincong Zhuo
  • Publication number: 20180282340
    Abstract: The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
    Type: Application
    Filed: March 20, 2018
    Publication date: October 4, 2018
    Inventors: Jincong Zhuo, Meizhong Xu, Chunhong He, Colin Zhang, Ding-Quan Qian, David M. Burns, Yun-Long Li, Brian Metcalf, Wenqing Yao